ArticleJournal of molecular biology2022

High-valency Anti-CD99 Antibodies Toward the Treatment of T Cell Acute Lymphoblastic Leukemia.

Larizbeth A Romero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.